Literature DB >> 18547153

Cardiovascular drugs: implications for dental practice. Part 2--antihyperlipidemics and antithrombotics.

Daniel E Becker1.   

Abstract

Appropriate preoperative assessment of the dental patient should always include an analysis of the patient's medications. Cardiovascular diseases are the most common group of medical disorders that dentists encounter, and the number of drugs prescribed for managing these conditions is staggering. This justifiably raises concern and probable confusion regarding side effects and possible drug interactions with medications the dentist may deem necessary for dental care. This continuing education article is the second in a series that will address essential pharmacology of medications commonly prescribed for chronic medical care. A reasonable understanding of these agents will allow the dentist to better appreciate the medical status of their patients, to appreciate the actual risks associated with antithrombotic medications, and to avoid adverse interactions with drugs the dentist might administer or prescribe.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547153      PMCID: PMC2424016          DOI: 10.2344/0003-3006(2008)55[49:CDIFDP]2.0.CO;2

Source DB:  PubMed          Journal:  Anesth Prog        ISSN: 0003-3006


  15 in total

1.  Effect of ibuprofen on cardioprotective effect of aspirin.

Authors:  T M MacDonald; L Wei
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

2.  Do NSAIDs interfere with the cardioprotective effects of aspirin?

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2004-08-02       Impact factor: 1.909

Review 3.  Evidence to continue oral anticoagulant therapy for ambulatory oral surgery.

Authors:  O Ross Beirne
Journal:  J Oral Maxillofac Surg       Date:  2005-04       Impact factor: 1.895

4.  Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

Authors:  Eugène P McFadden; Eugenio Stabile; Evelyn Regar; Edouard Cheneau; Andrew T L Ong; Timothy Kinnaird; William O Suddath; Neil J Weissman; Rebecca Torguson; Kenneth M Kent; August D Pichard; Lowell F Satler; Ron Waksman; Patrick W Serruys
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

Review 5.  Aspirin as an antiplatelet drug.

Authors:  C Patrono
Journal:  N Engl J Med       Date:  1994-05-05       Impact factor: 91.245

Review 6.  Surgical management of patients on warfarin sodium.

Authors:  O R Beirne; J R Koehler
Journal:  J Oral Maxillofac Surg       Date:  1996-09       Impact factor: 1.895

7.  Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jack Hirsh; Robert Raschke
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

8.  The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Jack Ansell; Jack Hirsh; Leon Poller; Henry Bussey; Alan Jacobson; Elaine Hylek
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  Use of aspirin and ibuprofen compared with aspirin alone and the risk of myocardial infarction.

Authors:  Taral N Patel; Kenneth Charles Goldberg
Journal:  Arch Intern Med       Date:  2004-04-26

10.  Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.

Authors:  Joseph A Delaney; Lucie Opatrny; James M Brophy; Samy Suissa
Journal:  CMAJ       Date:  2007-08-14       Impact factor: 8.262

View more
  2 in total

1.  Preoperative medical evaluation: part 1: general principles and cardiovascular considerations.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2009

2.  Perception of dental professionals towards dental management of patients using antithrombotic medications in Saudi Arabia: A cross-sectional survey.

Authors:  Mohammed AlSheef; Jenny Gray; Sarah Al Radhi; Majed AlJohani; Abdulaziz Al Johani; Abdul Rehman Zia Zaidi
Journal:  J Family Med Prim Care       Date:  2020-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.